BES_Mark.jpg
FATE THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
03 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fate Therapeutics, Inc....
BES_Mark.jpg
LI-CYCLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Li-Cycle, Corp. on Behalf of Li-Cycle Stockholders and Encourages Investors to Contact the Firm
03 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Li-Cycle, Corp....
BES_Mark.jpg
DOCGO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DocGo, Inc. and Encourages Investors to Contact the Firm
03 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
BES_Mark.jpg
FARFETCH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Farfetch Limited and Encourages Investors to Contact the Firm
03 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
BES_Mark.jpg
MPT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medical Properties Trust, Inc. and Encourages Investors to Contact the Firm
03 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
BES_Mark.jpg
ENVIVA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enviva Inc. and Encourages Investors to Contact the Firm
03 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
linkedin_logo_300x300.png
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of DocGo Inc. (DCGO) Investors and Encourages Investors to Contact the Firm Before December 26, 2023
03 nov. 2023 11h16 HE | Kirby McInerney LLP
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York...
BES_Mark.jpg
KEYCORP ALERT: Bragar Eagel & Squire, P.C. is Investigating KeyCorp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
02 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against KeyCorp (NYSE: KEY) on...
BES_Mark.jpg
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
02 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Masimo Corporation...
BES_Mark.jpg
APELLIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Apellis Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
02 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Apellis Pharmaceuticals,...